John Penn

March 7, 2025

BrightFocus Foundation announces appointment of John Penn to board of directors

A leader in the field of retinal disease research, Penn has been continuously funded as a principal investigator by the National Eye Institute of the National Institutes of Health since 1984.

December 9, 2021

Vision foundation’s longtime support key to Penn’s research efforts

By Nancy Humphrey

January 23, 2020

Insights on diabetic retinopathy

A drug that targets multiple pathogenic steps in diabetic retinopathy may be an ideal therapeutic strategy for the disease, Vanderbilt researchers report.

By Leigh MacMillan

January 21, 2016

New targets for diabetic retinopathy

Certain protein factors have been identified as attractive targets for treating diabetic retinopathy, a major cause of blindness in adults.

By VUMC News and Communications

February 12, 2015

VUMC’s Penn named president-elect of eye research society

John Penn, Ph.D., Phyllis G and William B. Snyder Endowed Professor of Ophthalmology and Visual Sciences, has been named president-elect of the International Society for Eye Research (ISER).

By Jessica Pasley

July 10, 2014

Meranze, Penn named to new Faculty Affairs roles

Two veteran faculty members are assuming new roles as associate deans within Vanderbilt University School of Medicine’s Office of Faculty Affairs.

By Nancy Humphrey

October 31, 2013

Penn named to vision group’s scientific advisory panel

John Penn, Ph.D., vice chair of the Department of Ophthalmology and Visual Sciences at Vanderbilt, has been named to the Research to Prevent Blindness (RPB) Scientific Advisory Panel.

By Jessica Pasley

March 7, 2013

Penn seeks new look at eye disorder

John Penn, Ph.D., vice chair of the Department of Ophthalmology and Visual Sciences at Vanderbilt, is seeking to change the way retinopathy of prematurity (ROP), the leading cause of childhood blindness worldwide, is treated.